Other studies have explored the frequency of ovarian cancer stem cells, identified as CD44+ALDH1+, in a large number of primary tumors: according to the level of CD44 expression the patients were subdivided into two subgroups, high expression (>20% CD44+ cells) and low expression (<20% CD44+ cells). The gene discussed is CD44; the disease is ovarian cancer.